EP3533792
Kristölluð form af andrógenviðtakastilli
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.6.2013EP published:
5.5.2021EP application number:
19169275.5
EP translation filed:
9.6.2021Grant published:
15.7.2021EPO information:
European Patent Register
Max expiry date:
3.6.2033Expiry date:
3.6.2026Next due date:
30.6.2026
Title:
CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR
Timeline
Today
4.6.2013EP application
5.5.2021EP Publication
9.6.2021Translation submitted
15.7.2021Registration published
3.6.2026Expires
Owner
Name:
Aragon Pharmaceuticals, Inc.Address:
10990 Wilshire Blvd. Suite 440, Los Angeles, CA 90024, US
Name:
Sloan Kettering Institute For Cancer ResearchAddress:
1275 York Avenue, New York, NY 10065, US
Inventor
Name:
DILHAS, AnnaAddress:
4055 Basel, CH
Name:
OUERFELLI, OuathekAddress:
Fort Lee, NJ 07024, US
Name:
SMITH, Nicholas D.Address:
San Diego, CA 92109, US
Name:
HERBERT, Mark R.Address:
San Diego, CA 92111, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261656888 PDate:
7.6.2012Country:
US
Supplementary protection
SPC number:
SPC356
Classification
Categories:
C07D 401/04, A61K 31/4439, A61K 31/4184, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 22.6.2021
Expires: 3.6.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 6.5.2022
Expires: 3.6.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 24.5.2023
Expires: 3.6.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.5.2024
Expires: 3.6.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 16.5.2025
Expires: 3.6.2026
Payer: Árnason Faktor ehf.